Press release
Global Artificial Intelligence in Diabetes Management Market 2024 : Trends, Business Growth And Major Driving Factors | Alphabet Inc., F. Hoffmann-La Roche AG, Abbott Laboratories, Medtronic Plc, Dexcom Inc.
Artificial Intelligence in Diabetes Management Global Market Report
The Business Research Company offers in-depth market insights through Artificial Intelligence in Diabetes Management Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The artificial intelligence in diabetes management market size has grown exponentially in recent years. It will grow from $0.48 billion in 2023 to $0.63 billion in 2024 at a compound annual growth rate (CAGR) of 31.6%. The growth in the historic period can be attributed to data accumulation, rising diabetes cases, healthcare cost pressures, early ai applications.
The artificial intelligence in diabetes management market size is expected to see exponential growth in the next few years. It will grow to $1.89 billion in 2028 at a compound annual growth rate (CAGR) of 31.7%. The growth in the forecast period can be attributed to ai-powered decision support systems, telemedicine integration, genomic data utilization, regulatory support. Major trends in the forecast period include advancements in wearable technology, personalized treatment plans, continuous glucose monitoring advances, ai-powered risk prediction, behavioral modification support.
Get Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12593&type=smp
Market Segmentation:
The artificial intelligence in diabetes management market covered in this report is segmented -
1) By Device: Diagnostic Devices, Glucose Monitoring Devices, Insulin Delivery Devices, Other Devices
2) By Techniques: Case-Based Reasoning, Intelligent Data Analysis
3) By End-Use: Hospitals, Clinics, Home Care Settings, Research Institutes
Major Driver - AI Revolution Is Transforming Diabetes Management In Response To Soaring Prevalence
The rising prevalence of diabetes is expected to propel artificial intelligence in the diabetes management market going forward. Diabetes occurs when the blood glucose, or blood sugar, is too high. Diabetes is a condition that causes various conditions such as eye problems, heart attacks and strokes, kidney problems, and others. Artificial intelligence is used to manage diabetes as it provides information about high or low blood sugar levels in a diabetic patient and collects data that has not been used previously. For instance, in December 2021, according to the International Diabetes Federation, a US-based intergovernmental organization, diabetes affected 537 million adults (20-79 years old) in 2021, and it is predicted that the number will climb to 643 million people by 2030 and 783 million by 2045. Therefore, the rising prevalence of diabetes is driving the growth of artificial intelligence in the diabetes management market.
Competitive Landscape:
Major companies operating in the artificial intelligence in diabetes management market report are Alphabet Inc., F. Hoffmann-La Roche AG, Abbott Laboratories, Medtronic Plc, Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., LifePlus Inc., Livongo Health Inc., Xeris Pharmaceuticals Inc., Virta Health Corp., Informed Data Systems Inc., Bigfoot Biomedical Inc., Lark Technologies Inc., Smart Meter LLC, Diabeloop SA, Quin Technology Ltd., Wellthy Therapeutics Pvt Ltd., Admetsys LLC, DreaMed Diabetes Ltd., Eyenuk Inc., Glooko Inc., PKvitality, Glytec LLC, Hygieia Inc., TypeZero Technologies Inc., Nemaura Medical Inc., GlucoMe, PredictBGL, Voluntis S.A.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-diabetes-management-global-market-report
Top Trend - Revolutionizing Diabetes Management Cutting-Edge Technological Advancements In Ai-Powered Solutions
Technological advancements are a key trend gaining popularity in the artificial intelligence in diabetes management market. Major companies operating in the artificial intelligence in diabetes management market are focused on innovating new and advanced technological solutions to sustain their position in the market. For instance, in October 2022, Dr. Mohan's Diabetes Specialties Center, an India-based diabetes specialty hospital chain, launched an innovative artificial intelligence-enabled platform for precision diabetes care with the 3D Initiative. The first of the three Ds is DIA, an AI-powered chatbot that can help individuals through pre-recorded digital interactions. The second is DIALA, a user-friendly smartphone app for patients; the last is DIANA, a medical app for precise diabetic care. According to the company, it is supported by the most advanced Total Experience (TX) Automation Platform, which powers an AI-enabled virtual assistant that interacts with patients on platforms such as Facebook Messenger, WhatsApp, Google Business Message, and the web.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Artificial Intelligence in Diabetes Management Market Characteristics
3. Artificial Intelligence in Diabetes Management Market Trends And Strategies
4. Artificial Intelligence in Diabetes Management Market - Macro Economic Scenario
5. Artificial Intelligence in Diabetes Management Market Size And Growth
…..
27. Artificial Intelligence in Diabetes Management Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Artificial Intelligence in Diabetes Management Market 2024 : Trends, Business Growth And Major Driving Factors | Alphabet Inc., F. Hoffmann-La Roche AG, Abbott Laboratories, Medtronic Plc, Dexcom Inc. here
News-ID: 3385854 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their…
